Patent US5836935A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5836935A Expired / Lapsed US ⏱️ 0.0 years remaining

Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body

Assignee: University of Kentucky Research Foundation
•
Filing: 1997-01-28
•
Granted: 1998-11-17
•
Expires: 2017-01-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An implantable, refillable, rate-controlled drug delivery device, with a hollow reservoir, and a drug delivery tube communicating with the hollow reservoir. The drug delivery tube includes at least one rate-limiting permeable membrane which regulates drug delivery. A method of controlling the delivery of a drug to an internal portion of a body is disclosed.

Inventors

  • 👤 Paul Ashton
  • 👤 Roy A. Patchell
  • 👤 Jon Cooper
  • 👤 Byron A. Young

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-28 17:34
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/0012; A61K9/0019; A61K9/0024; A61K9/0085; A61M; A61M31/00; A61M31/002; A61M39/00; A61M39/02; A61M39/0208

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 49 words
An implantable, refillable, rate controlled drug delivery device, comprising a hollow reservoir, a drug delivery tube communicating with the hollow reservoir, and one or more rate-limiting elements, said one or more elements consisting essentially of a permeable membrane in said drug delivery tube, which membrane passively regulates drug delivery.
Claim 2
Dependent Claim 49 words
An implantable, refillable, rate controlled drug delivery device, comprising a hollow reservoir, a drug delivery tube communicating with the hollow reservoir, and one or more rate-limiting elements, said one or more elements consisting essentially of a permeable membrane in said drug delivery tube, which membrane passively regulates drug delivery.
Claim 3
Dependent Claim 14 words
The device according to claim 1, wherein said device comprises two rate-limiting permeable membranes.
Claim 4
Dependent Claim 25 words
The device according to claim 1 wherein said rate-limiting permeable membrane is located between the hollow reservoir and an opening of the drug delivery tube.
Claim 5
Dependent Claim 28 words
The device according to claim 1, wherein said hollow reservoir contains a drug to be delivered at a controlled rate to an eternal target area of the body.
Claim 6
Dependent Claim 17 words
The device according to claim 4, wherein said internal target area of the body is the brain.
Claim 7
Dependent Claim 15 words
The device according to claim 1, further comprising a backing member circumscribing the hollow reservoir.
Claim 8
Dependent Claim 13 words
The device according to claim 6, wherein said backing member is a membrane.
Claim 9
Dependent Claim 44 words
A method of controlling the delivery of a anti-tumor drug to an internal portion of a body comprising administering an anti-tumor drug to an internal portion of the body through a device according to claim 1 to control the delivery of the anti-tumor drug.
Claim 10
Dependent Claim 31 words
A method for treating a brain tumor comprising administering an anti-tumor drug to a brain tumor through a device according to claim 1 to regulate drug delivery to the brain tumor.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2001-11-16 2002-05-18 2002-11-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2005-11-16 2006-05-18 2006-11-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2009-11-16 2010-05-18 2010-11-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag